Home - Products - Others - Other Targets - Atrial Natriuretic Peptide (126-150) (rat)

Atrial Natriuretic Peptide (126-150) (rat)

CAS No. 90052-57-6

Atrial Natriuretic Peptide (126-150) (rat)( ——— )

Catalog No. M41408 CAS No. 90052-57-6

Auriculin B (ANP (126-150) (Rat)) is a rat-derived atrial natriuretic peptide. Auriculin B has potent vasodilatory and diuretic properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote

Biological Information

  • Product Name
    Atrial Natriuretic Peptide (126-150) (rat)
  • Note
    Research use only, not for human use.
  • Brief Description
    Auriculin B (ANP (126-150) (Rat)) is a rat-derived atrial natriuretic peptide. Auriculin B has potent vasodilatory and diuretic properties.
  • Description
    Auriculin B (ANP (126-150) (Rat)) is a rat-derived atrial natriuretic peptide. Auriculin B has potent vasodilatory and diuretic properties.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    90052-57-6
  • Formula Weight
    2706.04
  • Molecular Formula
    C113H177N39O35S2
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Atlas SA, Laragh JH. Atrial natriuretic peptide: a new factor in hormonal control of blood pressure and electrolyte homeostasis. Annu Rev Med. 1986;37:397-414. ?
molnova catalog
related products
  • Difopein TFA (396834...

    Difopein (TFA), a specific and competitive inhibitor of 14-3-3 protein (a highly conserved eukaryotic regulatory molecule), blocking the ability of 14-3-3 to bind to target proteins and inhibits 14-3-3/Ligand interactions. Difopein (TFA) leads to induction of apoptosis and enhances the ability of cisplatin to kill cells.

  • Misonidazole

    Misonidazole as a novel GPX inhibitors to cause oxidative stress in chemotherapy-resistant tumors.

  • Fluoronaphthalene

    Incompatible with strong oxidizing agents.